在印度环境下，与传统抗球蛋白交叉配血程序相比，血型和筛查方法用于相容性检测的安全性。
Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
作者信息
Chaudhary Rajendra, Agarwal Nitin
机构信息
Department of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
出版信息
Asian J Transfus Sci. 2011 Jul;5(2):157-9. doi: 10.4103/0973-6247.83243.
Abstract
BACKGROUND
Over the past 30 years, pretransfusion tests have undergone considerable modification. In 1984, AABB recommended that the full cross match could be replaced by an abbreviated cross match in patients with negative antibody screen. However, before implementation of such a policy, issue regarding safety of T & S needs to be evaluated.
OBJECTIVES
The aim of pretransfusion testing (PTT) is to ensure that enough red blood cells (RBCs) in the selected red cell components will survive when transfused.
RESULTS AND CONCLUSION
We have, therefore in this study; evaluated safety of T & S procedure for PTT in comparison with conventional test tube cross match. The T & S procedure gave a safety of 91.6%. Also, the usefulness of the T & S was shown through the detection of unexpected antibodies in 0.75% (15 out of 2026) of cases.
摘要
背景
在过去30年中，输血前检测经历了相当大的改进。1984年，美国血库协会（AABB）建议，对于抗体筛查呈阴性的患者，完整交叉配血可被简化交叉配血取代。然而，在实施该政策之前，需要评估盐水配血试验（T&S）的安全性问题。
目的
输血前检测（PTT）的目的是确保所选红细胞成分中的足够红细胞在输血后能够存活。
结果与结论
因此，在本研究中，我们评估了盐水配血试验（T&S）用于输血前检测（PTT）相对于传统试管交叉配血的安全性。盐水配血试验（T&S）的安全性为91.6%。此外，通过在0.75%（2026例中的15例）的病例中检测到意外抗体，证明了盐水配血试验（T&S）的有效性。
相似文献
1
Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting.
Asian J Transfus Sci. 2011 Jul;5(2):157-9. doi: 10.4103/0973-6247.83243.
2
A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
Br J Haematol. 1992 Aug;81(4):579-84. doi: 10.1111/j.1365-2141.1992.tb02995.x.
3
Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
Asian J Transfus Sci. 2022 Jan-Jun;16(1):83-88. doi: 10.4103/ajts.ajts_138_20. Epub 2022 May 26.
4
First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774.
6
A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.
Immunohematology. 2022 Sep 22;38(3):100-105. doi: 10.21307/immunohematology-2022-050. Print 2022 Sep 1.
7
Safety and cost-containment data that advocate abbreviated pretransfusion testing.
Am J Clin Pathol. 1990 Oct;94(4):428-31. doi: 10.1093/ajcp/94.4.428.
8
Pre- and Post-Transfusion Alloimmunization in Dogs Characterized by 2 Antiglobulin-Enhanced Cross-match Tests.
J Vet Intern Med. 2017 Sep;31(5):1420-1429. doi: 10.1111/jvim.14801. Epub 2017 Aug 14.
9
Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
Transfusion. 1987 Mar-Apr;27(2):134-7. doi: 10.1046/j.1537-2995.1987.27287150183.x.
10
A reappraisal of pre-transfusion testing procedures in a hospital blood bank.
Pathology. 1985 Jul;17(3):489-92. doi: 10.3109/00313028509105506.
引用本文的文献
1
Implementing type and screen method replacing conventional antiglobulin crossmatch procedure for compatibility testing in elective protocol in a tertiary care hospital.
Asian J Transfus Sci. 2025 Jan-Jun;19(1):23-28. doi: 10.4103/ajts.ajts_112_22. Epub 2023 May 11.
2
Impact of Type and Screen Method on Turnaround Time and Man-Hour Utilization Compared to Conventional Coomb's Crossmatch: A Cross-Sectional Analytical Study.
Cureus. 2024 Sep 16;16(9):e69564. doi: 10.7759/cureus.69564. eCollection 2024 Sep.
3
Is It Time to Switch from Conventional Coombs Crossmatching to the Type and Screen Protocol?
Malays J Med Sci. 2023 Apr;30(2):124-130. doi: 10.21315/mjms2023.30.2.11. Epub 2023 Apr 18.
4
Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
Asian J Transfus Sci. 2022 Jan-Jun;16(1):83-88. doi: 10.4103/ajts.ajts_138_20. Epub 2022 May 26.
5
Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.
Asian J Transfus Sci. 2022 Jan-Jun;16(1):1-6. doi: 10.4103/ajts.AJTS_21_19. Epub 2022 May 26.
6
Retrospective Study on Prevalence, Specificity, Sex, and Age Distribution of Alloimmunization in Two General Hospitals in Athens.
Turk J Haematol. 2020 Aug 28;37(3):154-166. doi: 10.4274/tjh.galenos.2020.2019.0459. Epub 2020 Apr 22.
7
Benefits of VISION Max automated cross-matching in comparison with manual cross-matching: A multidimensional analysis.
PLoS One. 2019 Dec 23;14(12):e0226477. doi: 10.1371/journal.pone.0226477. eCollection 2019.
8
Antibody screening and identification in donors and general patients at a tertiary care teaching hospital in Western India.
Asian J Transfus Sci. 2019 Jan-Jun;13(1):34-38. doi: 10.4103/ajts.AJTS_94_17.
9
Advantages of type and screen policy: Perspective from a developing country!
Asian J Transfus Sci. 2018 Jan-Jun;12(1):42-45. doi: 10.4103/ajts.AJTS_31_17.
10
First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
Asian J Transfus Sci. 2017 Jan-Jun;11(1):40-44. doi: 10.4103/0973-6247.200774.
本文引用的文献
1
Blood inventory management in the type and screen era.
Vox Sang. 2005 Nov;89(4):245-50. doi: 10.1111/j.1423-0410.2005.00700.x.
2
Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. BCSH Blood Transfusion Task Force.
Transfus Med. 1996 Sep;6(3):273-83.
3
Incompatible crossmatch following nonreactive antibody detection test. Frequency and cause.
Transfusion. 1982 Mar-Apr;22(2):107-10. doi: 10.1046/j.1537-2995.1982.22282177114.x.
4
Pretransfusion tests and compatibility: questions of safety and efficacy.
Blood. 1982 May;59(5):873-5.
5
The risk of abbreviating the major crossmatch in urgent or massive transfusion.
Transfusion. 1978 Mar-Apr;18(2):137-41. doi: 10.1046/j.1537-2995.1978.18278160574.x.
6
The type and screen: a safe alternative and supplement in selected surgical procedures.
Transfusion. 1977 Mar-Apr;17(2):163-8. doi: 10.1046/j.1537-2995.1977.17277151923.x.
Zotero 插件